No healthcare sale, stresses Agfa
This article was originally published in Clinica
Executive Summary
Imaging and IT group Agfa-Gevaert this week quashed speculation that it was selling its healthcare business. The rumours were triggered by an article published on September 5 by Belgian daily newspaper, De Standaard, which claimed Agfa was preparing to sell the healthcare unit by the end of the year. Agfa confirmed to Clinica that the information in De Standaard was "misleading" and that it never launched – or made any preparations to launch – a process to auction the division. A spokesperson said that the firm's management remained committed "to the unity and the strategy of the healthcare division". Sales of Agfa's medical imaging and IT systems, which reached €607m ($844m) in H1 2008, make up around 40% of the group's total sales.
You may also be interested in...
Could Alcon's CyPass Trouble Be Boon For Glaukos – Or Bust For MIGS?
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roche Dx' EMEA Head To Take Charge After Diggelmann Departs
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Nose For A Good Tech? Philips Adds Nasal Alar Pulse Oximetry To Monitoring Portfolio
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.